Scottsdale, AZNCT06406114Now EnrollingIRB Ready

Antibiotic Allergy Clinical Trial in Scottsdale, AZ

Access cutting-edge antibiotic allergy treatment through this phase 2 clinical trial at a research site in Scottsdale. Study-provided care at no cost to qualified participants.

Sponsored by Massachusetts General Hospital

Quick Self-Assessment

See if you qualify for this Scottsdale location

Preparing your pre-screening questions…

Expert Care in Scottsdale

Access antibiotic allergy specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related antibiotic allergy treatment provided free

Apply for This Scottsdale Location

Check if you qualify for this antibiotic allergy clinical trial in Scottsdale, AZ

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Scottsdale

    Convenient for AZ residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Scottsdale site if eligible
  4. 4Begin participation

About This Antibiotic Allergy Study in Scottsdale

Cephalosporin antibiotics are commonly used but can result in allergic reactions and anaphylaxis. There is no clear diagnostic approach for cephalosporin-allergic patients, and guidance for the use of other antibiotics in allergic patients is based on side chain chemical similarity and limited skin testing evidence. This project includes a clinical trial and mechanistic studies to optimize the approach to cephalosporin allergy and advance future diagnostics.

Sponsor: Massachusetts General Hospital

Who Can Participate

Inclusion Criteria

Age 18-70 years old.
Reaction history consistent with a potential immediate hypersensitivity reaction (pruritus, urticaria, erythema, angioedema, bronchospasm, wheezing, shortness of breath, anaphylaxis, or hypotension) to cefazolin, ceftazidime, ceftriaxone, cefepime, cephalexin, cefaclor, cefadroxil, cefuroxime, cefpodoxime, cefdinir, or cefixime.
English speaking or non-English speaking with translation services available.

Exclusion Criteria

Severe concomitant medical condition (e.g., unstable coronary artery disease, congestive heart failure, severe chronic obstructive pulmonary disease, poorly controlled asthma, chronic renal failure, cirrhosis, or end-stage liver disease.)
History of Clostridioides difficile infection
Chronic spontaneous urticaria or systemic mastocytosis
Incident reaction required cardiopulmonary resuscitation
Reaction to 2 or more cephalosporin antibiotics
Active infection or antibiotic treatment within 7 days
Treatment with systemic antihistamines or corticosteroids within 7 days
Treatment with omalizumab or dupilumab within 60 days
Significant immunosuppression
Treatment with a beta-blocker or ACE inhibitor within 7 days
Use of investigational drugs within 60 days of participation
Anaphylaxis in the last 30 days
Penicillin anaphylaxis within the past year confirmed with positive penicillin skin tests
Prison or jail inmates, pregnant women, severe cognitive impairment
Current, diagnosed, mental illness or current, diagnosed, or self-reported drug or alcohol abuse that, in the opinion of the investigator, would interfere with the participant's ability to comply with study requirements
Past or current medical problems or findings from physical examination or laboratory testing that are not listed above, which, in the opinion of the investigator, may pose additional risks from participation in the study, may interfere with the participant's ability to comply with study requirements or that may impact the quality or interpretation of the data obtained from the study.
Inability or unwillingness of a participant to give written informed consent or comply with study protocol

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Scottsdale?

Yes, this clinical trial (NCT06406114) has an active research site in Scottsdale, AZ that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Antibiotic Allergy Treatment Options in Scottsdale, AZ

If you're searching for antibiotic allergy treatment options in Scottsdale, AZ, this clinical trial (NCT06406114) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Scottsdale research site is actively enrolling participants for this phase 2 clinical trial. You'll receive care from experienced antibiotic allergy specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all antibiotic allergy clinical trials near you to find additional studies recruiting in your area.

More Leukemia Trials in Scottsdale, AZ

See all leukemia clinical trials recruiting in Scottsdale — not just this study.

Browse Leukemia Trials in Scottsdale →

Browse More Trials by Condition

Leukemia TrialsInterstitial Cystitis TrialsAll Conditions →

Ready to Join in Scottsdale?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Scottsdale, AZ